Target intelligence / Profile preview

Eukaryotic translation elongation factor 1 gamma pseudogene 3 (EEF1GP3)

Target
EEF1GP3
Molecular classification
Other, Pseudogene
01

Overview

**Eukaryotic translation elongation factor 1 gamma pseudogene 3 (EEF1GP3)** is a predicted processed pseudogene related to the gene encoding eukaryotic translation elongation factor 1 gamma (EEF1G)[1][3][5]. EEF1G is a structural and regulatory subunit of the eukaryotic translation elongation factor 1 complex, which is involved in protein synthesis, but EEF1GP3 itself is not protein-coding and is not considered a functional gene or therapeutic target[1][3]. According to genome sequence analyses, EEF1GP3 is predicted by computational methods and is not supported by experimental evidence for any protein- or RNA-coding function currently[1]. There is no direct information on biological functions, disease roles, drug interactions, or clinical utility for EEF1GP3.\n\n**Key details and context:**\n- EEF1GP3 is classified as a pseudogene, meaning it is a DNA sequence related to a gene but typically non-functional due to mutations or lack of regulatory elements necessary for expression[1][3][5].\n- Unlike some other pseudogenes which may be transcribed into non-coding RNAs with potential regulatory functions, EEF1GP3 is only predicted computationally and is not experimentally validated to show any expression or function[1].\n- Pseudogenes of the EEF1G family, including EEF1GP3, are not considered therapeutic targets or druggable entities[1].\n- EEF1G (the functional gene) is part of the elongation factor 1 complex involved in translational elongation in eukaryotes, but there is no evidence that its pseudogenes, such as EEF1GP3, participate in these or other biological functions[1][2][4].\n- There are no known interacting drugs, mechanisms of action, biomarker roles, or safety concerns for EEF1GP3.\n\n**Additional notes:**\n- EEF1GP3 should not be confused with EEF1G, the functional gene.\n- Because it is a predicted pseudogene with no known transcription or function, EEF1GP3 is not considered a \"target\" in drug discovery or molecular medicine[1][3][5].

Other names
EEF1GP3
02

Biological functions

Other
03

Disease associations

Other

Beyond the preview

Go deeper on Eukaryotic translation elongation factor 1 gamma pseudogene 3 (EEF1GP3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eukaryotic translation elongation factor 1 gamma pseudogene 3 (EEF1GP3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call